✦ LIBER ✦

Overview of cardiovascular physiologic and pharmacologic aspects of selective phosphodiesterase peak III inhibitors

✍ Scribed by Dale B. Evans

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular effects of forskolin and

✍ M. Schlepper; J. Thormann; V. Mitrovic 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 1022 KB

Controlled and uncontrolled studies of p

✍ William B. Hood Jr. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 1016 KB

Enzymological and pharmacological profil

✍ Hideki Mochida; Michino Takagi; Hirotaka Inoue; Tsunehisa Noto; Koji Yano; Kotom 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 158 KB

[Handbook of Experimental Pharmacology]

✍ Francis, Sharron H.; Conti, Marco; Houslay, Miles D. 📂 Article 📅 2011 🏛 Springer Berlin Heidelberg ⚖ 616 KB

Pharmacological and biochemical study on

✍ M. Bardou; J Cortijo; C. Loustalot; S. Taylor; A. Perales-Marín; F.J. Mercier; M 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 69 KB

[Handbook of Experimental Pharmacology]

✍ Francis, Sharron H.; Conti, Marco; Houslay, Miles D. 📂 Article 📅 2011 🏛 Springer Berlin Heidelberg ⚖ 332 KB